{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T18:20:46Z","timestamp":1794594046677,"version":"4.9.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jclinepi.2025.111736","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T19:06:45Z","timestamp":1740510405000},"page":"111736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Performance of the revised World Health Organization cardiovascular disease risk prediction models for the Middle East and North Africa: a validation study in the Tehran Lipid and Glucose Study"],"prefix":"10.1016","volume":"182","author":[{"given":"Mahin","family":"Nomali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yaseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saharnaz","family":"Nedjat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Mansournia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Navid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goodarz","family":"Danaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noushin","family":"Fahimfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewout","family":"Steyerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4956-1039","authenticated-orcid":false,"given":"Davood","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jclinepi.2025.111736_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111736_bib2","first-page":"204","article-title":"Cardiovascular disease in Iran in the last 40 Years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention","volume":"22","author":"Sarrafzadegan","year":"2019","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.jclinepi.2025.111736_bib3","article-title":"Primary prevention of cardiovascular disease: updated review of contemporary guidance and literature","volume":"9","author":"Stewart","year":"2020","journal-title":"JRSM Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.jclinepi.2025.111736_bib4","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of cardiology\/American heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jclinepi.2025.111736_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.5603\/KP.2016.0120","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice","volume":"74","author":"Piepoli","year":"2016","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jclinepi.2025.111736_bib6","series-title":"HEARTS technical package for cardiovascular disease management in primary health care: risk based CVD management. Licence: CC BY-NC-SA 3.0 IGO","year":"2020"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111736_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jclinepi.2025.111736_bib8","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.108.814251","article-title":"C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation"},{"issue":"1 Pt 2","key":"10.1016\/j.jclinepi.2025.111736_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1991","journal-title":"Am Heart J"},{"issue":"25 Suppl 2","key":"10.1016\/j.jclinepi.2025.111736_bib10","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111736_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/hrt.2006.108167","article-title":"Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)","volume":"93","author":"Woodward","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jclinepi.2025.111736_bib12","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111736_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/hc0302.102575","article-title":"Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular M\u00fcnster (PROCAM) study","volume":"105","author":"Assmann","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111736_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-8587(17)30015-3","article-title":"Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys","volume":"5","author":"Ueda","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.jclinepi.2025.111736_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2213-8587(15)00081-9","article-title":"A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys","volume":"3","author":"Hajifathalian","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jclinepi.2025.111736_bib16","series-title":"Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk","year":"2007"},{"issue":"10","key":"10.1016\/j.jclinepi.2025.111736_bib17","doi-asserted-by":"crossref","first-page":"e1332","DOI":"10.1016\/S2214-109X(19)30318-3","article-title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions","volume":"7","year":"2019","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111736_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/vhrm.1.1.15.58933","article-title":"Cardiovascular risk assessment and management in developing countries","volume":"1","author":"Mendis","year":"2005","journal-title":"Vasc Health Risk Manag"},{"issue":"5","key":"10.1016\/j.jclinepi.2025.111736_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00038-015-0733-4","article-title":"Cardiovascular risk models for South Asian populations: a systematic review","volume":"61","author":"Gopal","year":"2016","journal-title":"Int J Publ Health"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111736_bib20","first-page":"77","article-title":"Tehran lipid and glucose study (TLGS): rationale and design","volume":"2","author":"Azizi","year":"2000","journal-title":"Iran J Endocrinol Metabol"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111736_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.jclinepi.2025.111736_bib22","series-title":"Clinical prediction models","author":"Steyerberg","year":"2019"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111736_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.2517-6161.1958.tb00292.x","article-title":"The regression analysis of binary sequences","volume":"20","author":"Cox","year":"1958","journal-title":"J Roy Stat Soc B"},{"key":"10.1016\/j.jclinepi.2025.111736_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111736_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1742-1241.2010.02529.x","article-title":"Predictive accuracy of the 'framingham's general CVD algorithm' in a middle eastern population: tehran lipid and glucose study","volume":"65","author":"Bozorgmanesh","year":"2011","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111736_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/aje\/kws204","article-title":"Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study","volume":"176","author":"Khalili","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111736_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12967-020-02434-5","article-title":"External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population","volume":"18","author":"Asgari","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.jclinepi.2025.111736_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijcard.2015.03.067","article-title":"A new approach to test validity and clinical usefulness of the 2013 ACC\/AHA guideline on statin therapy: a population-based study","volume":"184","author":"Khalili","year":"2015","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111736_bib29","first-page":"210","article-title":"Prediction of cardiovascular disease mortality in a middle eastern country: performance of the globorisk and score functions in four population-based cohort studies of Iran","volume":"11","author":"Fahimfar","year":"2022","journal-title":"Int J Health Pol Manag"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111736_bib30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1186\/s12889-021-10760-6","article-title":"Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)","volume":"21","author":"Koohi","year":"2021","journal-title":"BMC Public Health"},{"issue":"4 Suppl","key":"10.1016\/j.jclinepi.2025.111736_bib31","article-title":"Review of rationale, design, and initial findings: tehran lipid and glucose study","volume":"16","author":"Azizi","year":"2018","journal-title":"Int J Endocrinol Metabol"},{"issue":"8","key":"10.1016\/j.jclinepi.2025.111736_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105804","article-title":"The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study","volume":"9","author":"Khalili","year":"2014","journal-title":"PLoS One"},{"issue":"4 Suppl","key":"10.1016\/j.jclinepi.2025.111736_bib33","article-title":"Outcomes of a longitudinal population-based cohort study and pragmatic community trial: findings from 20 Years of the tehran lipid and glucose study","volume":"16","author":"Khalili","year":"2018","journal-title":"Int J Endocrinol Metabol"},{"key":"10.1016\/j.jclinepi.2025.111736_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-6215-10-5","article-title":"Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II","volume":"10","author":"Azizi","year":"2009","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111736_bib35","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1542\/peds.2006-1801","article-title":"Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force","volume":"120","author":"Haney","year":"2007","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jclinepi.2025.111736_bib36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jclinepi.2004.06.017","article-title":"Substantial effective sample sizes were required for external validation studies of predictive logistic regression models","volume":"58","author":"Vergouwe","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111736_bib37","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111736_bib38","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.jclinepi.2025.111736_bib39","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jclinepi.2006.01.015","article-title":"Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example","volume":"59","author":"van der Heijden","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111736_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jclinepi.2020.03.028","article-title":"Missing data should be handled differently for prediction than for description or causal explanation","volume":"125","author":"Sperrin","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.jclinepi.2025.111736_bib41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111736_bib42","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1536867X1801700414","article-title":"Assessing the calibration of dichotomous outcome models with the calibration belt","volume":"17","author":"Nattino","year":"2017","journal-title":"STATA J"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111736_bib43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","article-title":"Reporting and interpreting decision curve analysis: a guide for investigators","volume":"74","author":"Van Calster","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.jclinepi.2025.111736_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inf Decis Making"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111736_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.jclinepi.2025.111736_bib46","article-title":"Validating World Health Organization cardiovascular disease risk charts and optimizing risk assessment in China","volume":"8","author":"Li","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jclinepi.2025.111736_bib47","article-title":"Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population","volume":"35","author":"Kasim","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jclinepi.2025.111736_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2017.10.027","article-title":"C-statistic: a brief explanation of its construction, interpretation and limitations","volume":"90","author":"Caetano","year":"2018","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111736_bib49","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2471\/BLT.22.288645","article-title":"WHO cardiovascular disease risk prediction model performance in 10 regions, China","volume":"101","author":"Yang","year":"2023","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111736_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12872-016-0462-5","article-title":"Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics","volume":"17","author":"Backholer","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"10.1016\/j.jclinepi.2025.111736_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292396","article-title":"Validity of the models predicting 10-year risk of cardiovascular diseases in Asia: a systematic review and prediction model meta-analysis","volume":"18","author":"Nomali","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111736_bib52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:14:06Z","timestamp":1762316046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435625000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":52,"alternative-id":["S0895435625000691"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111736","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of the revised World Health Organization cardiovascular disease risk prediction models for the Middle East and North Africa: a validation study in the Tehran Lipid and Glucose Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111736"}}